Science & Translation Stem cell medicine in the North: The report

When the experts meet in Hamburg in July for the most important global congress in stem cell research – the ISSCR Annual Meeting – many regional players from the Life Science Nord cluster will also be there. A guide to the region's major players in research and industry in the stem cell field.

Portrait AI and crystals: “We provide the blueprint for innovative drug design”

The start-up CrystalsFirst specializes in structural biological analyses of protein crystals for drug development. The team has been based at DESY in Hamburg-Bahrenfeld since 2022. In this interview, founder and CEO Serghei Glinca talks about the technology and the structural biology ecosystem in the North of Germany.

Networking|Portrait Our Chairwoman for Regulatory Affairs: Heike Wachenhausen

Heike Wachhausen has been our honorary chairwoman at Life Science Nord e.V. since autumn 2021. She is our trusted contact for all regulatory affairs issues.

Innovation Kiel: Translating marine sciences into medicine

The BlueHealthTech alliance from Kiel wants to be able to combat chronic diseases before symptoms appear. They have been supported with 15 million euros in funding since 2021. Find out more here.

Business Nord How Nordmark is on course for growth with biotechnology

Nordmark invests 20 million euros in biotechnology and enters into partnerships to accelerate processes. Its goals include the fight against cancer in children. Find out more here.

Innovation|Science & Translation Fighting cancer with powerful bioinformatics and AI

In hardly any other field has the concept of personalized medicine become a clinical reality as it much as in the battle against cancer. Digitization and the advent of powerful data analytics tools such as machine learning drive this development. Here is a selection of players from the North that are leading the field.

How Nordmark is on course for growth with biotechnology

Business Nord How Nordmark is on course for growth with biotechnology

Nordmark invests 20 million euros in biotechnology and enters into partnerships to accelerate processes. Its goals include the fight against cancer in children. Find out more here.

Fighting cancer with powerful bioinformatics and AI

Innovation|Science & Translation Fighting cancer with powerful bioinformatics and AI

In hardly any other field has the concept of personalized medicine become a clinical reality as it much as in the battle against cancer. Digitization and the advent of powerful data analytics tools such as machine learning drive this development. Here is a selection of players from the North that are leading the field.

Opening up health data for precision medicine

Innovation Opening up health data for precision medicine

Digitization of healthcare is a major driver of precision medicine, but the generation and usage of health data is a complex task. Pharma, biotech and medtech players from Northern Germany find their way through the challenge and explore new ways of cross-sectoral collaboration.

How 3D printing contributes to precision medicine

Science & Translation How 3D printing contributes to precision medicine

Researchers in the North combine artificial intelligence with state-of-the-art additive manufacturing technologies and develop bioresorbable materials and innovative bioprinting techniques to take precision medicine to the next level.

By category

Stem cell medicine in the North: The report

Science & Translation Stem cell medicine in the North: The report

When the experts meet in Hamburg in July for the most important global congress in stem cell research – the ISSCR Annual Meeting – many regional players from the Life Science Nord cluster will also be there. A guide to the region's major players in research and industry in the stem cell field.

AI and crystals: “We provide the blueprint for innovative drug design”

Portrait AI and crystals: “We provide the blueprint for innovative drug design”

The start-up CrystalsFirst specializes in structural biological analyses of protein crystals for drug development. The team has been based at DESY in Hamburg-Bahrenfeld since 2022. In this interview, founder and CEO Serghei Glinca talks about the technology and the structural biology ecosystem in the North of Germany.

Our Chairwoman for Regulatory Affairs: Heike Wachenhausen

Networking|Portrait Our Chairwoman for Regulatory Affairs: Heike Wachenhausen

Heike Wachhausen has been our honorary chairwoman at Life Science Nord e.V. since autumn 2021. She is our trusted contact for all regulatory affairs issues.

Kiel: Translating marine sciences into medicine

Innovation Kiel: Translating marine sciences into medicine

The BlueHealthTech alliance from Kiel wants to be able to combat chronic diseases before symptoms appear. They have been supported with 15 million euros in funding since 2021. Find out more here.

How Nordmark is on course for growth with biotechnology

Business Nord How Nordmark is on course for growth with biotechnology

Nordmark invests 20 million euros in biotechnology and enters into partnerships to accelerate processes. Its goals include the fight against cancer in children. Find out more here.

Fighting cancer with powerful bioinformatics and AI

Innovation|Science & Translation Fighting cancer with powerful bioinformatics and AI

In hardly any other field has the concept of personalized medicine become a clinical reality as it much as in the battle against cancer. Digitization and the advent of powerful data analytics tools such as machine learning drive this development. Here is a selection of players from the North that are leading the field.

Popular

Stem cell medicine in the North: The report

Science & Translation Stem cell medicine in the North: The report

When the experts meet in Hamburg in July for the most important global congress in stem cell research – the ISSCR Annual Meeting – many regional players from the Life Science Nord cluster will also be there. A guide to the region's major players in research and industry in the stem cell field.

AI and crystals: “We provide the blueprint for innovative drug design”

Portrait AI and crystals: “We provide the blueprint for innovative drug design”

The start-up CrystalsFirst specializes in structural biological analyses of protein crystals for drug development. The team has been based at DESY in Hamburg-Bahrenfeld since 2022. In this interview, founder and CEO Serghei Glinca talks about the technology and the structural biology ecosystem in the North of Germany.

Our Chairwoman for Regulatory Affairs: Heike Wachenhausen

Networking|Portrait Our Chairwoman for Regulatory Affairs: Heike Wachenhausen

Heike Wachhausen has been our honorary chairwoman at Life Science Nord e.V. since autumn 2021. She is our trusted contact for all regulatory affairs issues.

Kiel: Translating marine sciences into medicine

Innovation Kiel: Translating marine sciences into medicine

The BlueHealthTech alliance from Kiel wants to be able to combat chronic diseases before symptoms appear. They have been supported with 15 million euros in funding since 2021. Find out more here.